首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING ALPHA-CUBEBENOATE DERIVED FROM SCHISANDRA CHINENSIS AS ACTIVE INGREDIENT

COMPOSITION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING ALPHA-CUBEBENOATE DERIVED FROM SCHISANDRA CHINENSIS AS ACTIVE INGREDIENT

机译:预防或治疗败血症或败血症性休克的成分,其包含五味子碱作为活性成分

摘要

The present invention relates to a composition including α-cubebenoate derived from Schisandra chinensis as an active ingredient, and more particularly to a pharmaceutical composition for treating or preventing sepsis or septic shock including α-cubebenoate or a pharmaceutically acceptable salt thereof as an active ingredient, and a health functional food for preventing or alleviating sepsis or septic shock including α-cubebenoate as an active ingredient. The α-cubebenoate according to the present invention exhibits, in a sepsis model, pulmonary inflammation block, bactericidal activity through phagocytosis and induction of hydrogen peroxide production, and an effect of blocking proinflammatory cytokine production, so that it is expected that the α-cubebenoate can be usefully applied to treatment of sepsis or septic shock.;COPYRIGHT KIPO 2016
机译:本发明涉及一种组合物,其包含源自五味子的五味子酸酯作为活性成分,并且更具体地涉及一种用于治疗或预防败血症或败血性休克的药物组合物,其包括α-魔方酸酯或其药学上可接受的盐作为活性成分。成分,以及用于预防或减轻败血症或败血性休克的保健功能食品,其中包括α-立方立方体酸酯作为有效成分。在脓毒症模型中,根据本发明的α-立方体酯显示出肺部炎症阻滞,通过吞噬作用和过氧化氢的诱导的杀菌活性以及阻断促炎性细胞因子产生的作用,因此可以预期α -立方山雀酸酯可有效用于治疗败血症或败血性休克。; COPYRIGHT KIPO 2016

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号